Counting on Capital: Private Equity Perspectives

In our third episode of the Industry Perspective we interview Adam Weinstein, CFO of New Mountain Capital. 

2020 has been an unprecedented year and the impact of COVID-19 has rippled through the world's economy. Join us for today's episode where Adam shares his perspective on the pandemic's impact on the private equity industry and his belief that private equity can play offense in the fight to defeat the virus.  

In our third episode of the Industry Perspective we interview Adam Weinstein, CFO of New Mountain Capital. 

2020 has been an unprecedented year and the impact of COVID-19 has rippled through the world's economy. Join us for today's episode where Adam shares his perspective on the pandemic's impact on the private equity industry and his belief that private equity can play offense in the fight to defeat the virus.  

In our second episode of the Industry Perspective we interview Russ Steenberg, Global Head of Private Equity Partners at BlackRock.

Join us as Russ shares his story of building a career in private equity and his unique perspective on the industry. Russ has sat on both sides of the fence as someone who once worked at pension funds that invested in private equity and later went on to help start a fund from scratch. In today’s episode Russ shares his journey and his formula of “p to the 4th” on how to evaluate private equity firms for success. 

In our second episode of the Industry Perspective we interview Russ Steenberg, Global Head of Private Equity Partners at BlackRock.

Join us as Russ shares his story of building a career in private equity and his unique perspective on the industry. Russ has sat on both sides of the fence as someone who once worked at pension funds that invested in private equity and later went on to help start a fund from scratch. In today’s episode Russ shares his journey and his formula of “p to the 4th” on how to evaluate private equity firms for success. 

We’re back! Today we’re launching our new segment, the Industry Perspective, featuring leaders across the private equity industry. 

In our first episode of this segment we interview Steve Klinsky, CEO and founder of New Mountain Capital. 

Join us as we discuss Steve’s vision for private equity, his journey in founding New Mountain capital and his advice for young people who are interested in private equity. 

We’re back! Today we’re launching our new segment, the Industry Perspective, featuring leaders across the private equity industry. 

In our first episode of this segment we interview Steve Klinsky, CEO and founder of New Mountain Capital. 

Join us as we discuss Steve’s vision for private equity, his journey in founding New Mountain capital and his advice for young people who are interested in private equity. 

In our final episode of the Portfolio Perspective we interview Nathan Goldstein, Chief Strategy Officer of Signify Health, a company dedicated to revolutionizing healthcare and bringing healthcare to a patient’s home. 

Join us as we discuss Signify's vision for healthcare and their experience working with private equity. 

In our final episode of the Portfolio Perspective we interview Nathan Goldstein, Chief Strategy Officer of Signify Health, a company dedicated to revolutionizing healthcare and bringing healthcare to a patient’s home. 

Join us as we discuss Signify's vision for healthcare and their experience working with private equity. 

In our fourth episode of the Portfolio Perspective we interview Joshua Shultz, CEO of Cytel, a company dedicated to shaping the future of drug development.  

Join us as we discuss Cytel's experience working with private equity, the future of drug development, and how Cytel is helping in the global race to find a vaccine. 

In our fourth episode of the Portfolio Perspective we interview Joshua Shultz, CEO of Cytel, a company dedicated to shaping the future of drug development.  

Join us as we discuss Cytel's experience working with private equity, the future of drug development, and how Cytel is helping in the global race to find a vaccine.